XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements Of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Non- controlling Interest
Balance, beginning of year (in shares) at Dec. 31, 2018     52,941,607 1,430,094          
Balance, beginning of period at Dec. 31, 2018 $ 2,206,235   $ 5 $ (224,998) $ 744,937 $ 1,848,500   $ (162,896) $ 687
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     259,749            
Exercise of stock options and vesting of RSU's and PSU's (2,321)       (2,321)        
Common stock issued under employee stock purchase plan (in shares)     31,483            
Common stock issued under employee stock purchase plan 3,965       3,965        
Purchased common stock (in shares)     (196,996) (196,996)          
Purchased common stock (25,921)     $ (25,921)          
Stock-based compensation 25,571       25,571        
Net income 184,564         184,684     (120)
Foreign currency translation adjustments (11,431)             (11,413) (18)
Unrealized (loss) gain on derivatives (2)             (2)  
Balance, end of period (in shares) at Sep. 30, 2019     53,035,843 1,627,090          
Balance, end of period at Sep. 30, 2019 2,380,660   $ 5 $ (250,919) 772,152 2,033,184   (174,311) 549
Balance, beginning of year (in shares) at Jun. 30, 2019     53,182,910 1,446,470          
Balance, beginning of period at Jun. 30, 2019 2,367,361   $ 5 $ (227,282) 761,936 1,975,931   (143,943) 714
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     33,553            
Exercise of stock options and vesting of RSU's and PSU's 1,676       1,676        
Purchased common stock (in shares)     (180,620) (180,620)          
Purchased common stock (23,637)     $ (23,637)          
Stock-based compensation 8,540       8,540        
Net income 57,127         57,253     (126)
Foreign currency translation adjustments (30,410)             (30,371) (39)
Unrealized (loss) gain on derivatives 3             3  
Balance, end of period (in shares) at Sep. 30, 2019     53,035,843 1,627,090          
Balance, end of period at Sep. 30, 2019 2,380,660   $ 5 $ (250,919) 772,152 2,033,184   (174,311) 549
Balance, beginning of year (in shares) at Dec. 31, 2019     53,010,875 1,732,352          
Balance, beginning of period at Dec. 31, 2019 2,402,443 $ (115) $ 5 $ (265,730) 785,636 2,028,734 $ (115) (146,919) 717
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     514,717            
Exercise of stock options and vesting of RSU's and PSU's 14,217   $ 1   14,216        
Common stock issued under employee stock purchase plan (in shares)     20,484            
Common stock issued under employee stock purchase plan 2,550       2,550        
Purchased common stock (in shares)     (301,660) (301,660)          
Purchased common stock (37,884)     $ (37,884)          
Stock-based compensation 26,394       26,394        
Net income 110,662         110,233     429
Foreign currency translation adjustments (46,445)             (46,160) (285)
Unrealized (loss) gain on derivatives (516)             (516)  
Adjustment for net gain realized and included in net income (232)             (232)  
Balance, end of period (in shares) at Sep. 30, 2020     53,244,416 2,034,012          
Balance, end of period at Sep. 30, 2020 2,471,074   $ 6 $ (303,614) 828,796 2,138,852   (193,827) 861
Balance, beginning of year (in shares) at Jun. 30, 2020     53,182,148 1,972,540          
Balance, beginning of period at Jun. 30, 2020 2,437,306   $ 6 $ (293,960) 811,559 2,103,248   (184,501) 954
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     123,740            
Exercise of stock options and vesting of RSU's and PSU's 8,497       8,497        
Purchased common stock (in shares)     (61,472) (61,472)          
Purchased common stock (9,654)     $ (9,654)          
Stock-based compensation 8,740       8,740        
Net income 35,530         35,604     (74)
Foreign currency translation adjustments (8,562)             (8,543) (19)
Unrealized (loss) gain on derivatives (551)             (551)  
Adjustment for net gain realized and included in net income (232)             (232)  
Balance, end of period (in shares) at Sep. 30, 2020     53,244,416 2,034,012          
Balance, end of period at Sep. 30, 2020 $ 2,471,074   $ 6 $ (303,614) $ 828,796 $ 2,138,852   $ (193,827) $ 861